The Interplay between the Glucocorticoid Receptor and Nuclear Factor-κB or Activator Protein-1: Molecular Mechanisms for Gene Repression
The DOI matches its Crossref record; 791 of the 808 references it cites were found in a registry or an index.
Abstract
The inflammatory response is a highly regulated physiological process that is critically important for homeostasis. A precise physiological control of inflammation allows a timely reaction to invading pathogens or to other insults without causing overreaction liable to damage the host. The cellular signaling pathways identified as important regulators of inflammation are the signal transduction cascades mediated by the nuclear factor-kappaB and the activator protein-1, which can both be modulated by glucocorticoids. Their use in the clinic includes treatment of rheumatoid arthritis, asthma, allograft rejection, and allergic skin diseases. Although glucocorticoids have been widely used since the late 1940s, the molecular mechanisms responsible for their antiinflammatory activity are still under investigation. The various molecular pathways proposed so far are discussed in more detail.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It acts through the glucocorticoid receptor (GR), which modulates gene expression by suppressing pro-inflammatory signaling pathways involving transcription factors such as NF-κB and AP-1 [18].”
From Chronic Stress and Autoimmunity: The Role of HPA Axis and Cortisol Dysregulation (2025) · cites this paper as [18]
In the citing paper
“GCs also decrease immune activation via protein-protein interactions between GR and NF-κB in the nucleus (Figure 1) (De Bosscher et al., 2003).”
From The Stressed CNS: When Glucocorticoids Aggravate Inflammation (2009) · cites this paper as De Bosscher et al., 2003
In the citing paper
“Moreover, chronic exposure to GCs (particularly synthetic GCs at supra-physiological levels) inhibits both innate and adaptive immunity.”
From The Stressed CNS: When Glucocorticoids Aggravate Inflammation (2009) · cites this paper as De Bosscher et al., 2003
In the citing paper
“For example, chronic GC exposure reduces circulating leukocyte counts and decreases the production of a large variety of proinflammatory cytokines including IL-1β and TNF-α (De Bosscher et al., 2003).”
From The Stressed CNS: When Glucocorticoids Aggravate Inflammation (2009) · cites this paper as De Bosscher et al., 2003
Citations
Cites
2 retracted
Items 401–600 of 791
Mechanism of gene expression by the glucocorticoid receptor: Role of protein‐protein interactions
McEwan, I. J., Wright, A. P. H., & Gustafsson, J. (1997) · BioEssays · doi:10.1002/bies.950190210 · Cited by 178 · cited 1×
“Over the last 10 yr, a vast amount of novel proteins interacting with members of the NR superfamily were identified by two-hybrid screening, functional complementation studies, far-Western blotting, and expression cloning (101, 262).”
BackgroundA New Function for the C-terminal Zinc Finger of the Glucocorticoid Receptor
Lidén, J., Delaunay, F., Rafter, I., Gustafsson, J.-Å., & Okret, S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21467 · Cited by 177 · cited 4×
“GR, ER, and TR ) has proven the importance of the GR DBD both in transactivation and transrepression (102, 211, 230).”
BackgroundInfluentialDynamic Remodeling of Transcription Complexes by Molecular Chaperones
Morimoto, R. I. (2002) · Cell · doi:10.1016/s0092-8674(02)00860-7 · Cited by 177
Act1, an NF-κB-activating protein
Li, X., Commane, M., Nie, H., Hua, X., Chatterjee-Kishore, M., Wald, D., Haag, M., & Stark, G. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160265197 · Cited by 176
Müller, J. R., & Siebenlist, U. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210768200 · Cited by 176
Lee, Y.-H., Koh, S. S., Zhang, X., Cheng, X., & Stallcup, M. R. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.11.3621-3632.2002 · Cited by 175
Schaaf, M. J. M., & Cidlowski, J. A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.6.1922-1934.2003 · Cited by 173 · cited 2×
“ulating distinct aspects of receptor function (168, 534, 547).”
BackgroundSong, C.-Z., Tian, X., & Gelehrter, T. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.11776 · Cited by 171
Doucas, V., Tini, M., Egan, D. A., & Evans, R. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2627 · Cited by 170
Glucocorticoid signalling—multiple variations of a common theme
Reichardt, H. M., & Schütz, G. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00208-1 · Cited by 170 · cited 2×
“They suppress the production and effects of humoral factors involved in the inflammatory response (104, 196).”
BackgroundZhang, X. (1998) · Molecular Endocrinology · doi:10.1210/me.12.4.513 · Cited by 169
Positive Effects of Glucocorticoids on T Cell Function by Up-Regulation of IL-7 Receptor α
Franchimont, D., Galon, J., Vacchio, M. S., Fan, S., Visconti, R., Frucht, D. M., Geenen, V., Chrousos, G. P., Ashwell, J. D., & O’Shea, J. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2212 · Cited by 168
Modulation of glucocorticoid receptor function by protein kinase A
Rangarajan, P. N. (1992) · Molecular Endocrinology · doi:10.1210/me.6.9.1451 · Cited by 168
AP-1--glucocorticoid receptor crosstalk taken to a higher level
Karin, M., & Chang, L. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1690447 · Cited by 167 · cited 1×
“Recent studies conducted at the whole animal level further extend the AP-1-GC cross-talk to a higher order, because JNK activity can modulate levels of circulating GCs (719).”
BackgroundMolecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia
Tissing, W. J. E., Meijerink, J. P. P., den Boer, M. L., & Pieters, R. (2003) · Leukemia · doi:10.1038/sj.leu.2402733 · Cited by 167
Activation of the AP-1 transcription factor by inflammatory cytokines of the TNF family.
Kyriakis, J. M. (1999) · Europe PMC (PubMed Central) · Cited by 165
Regulation of β-Catenin Function by the IκB Kinases
Lamberti, C., Lin, K., Yamamoto, Y., Verma, U. N., Verma, I. M., Byers, S., & Gaynor, R. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104227200 · Cited by 165
McKay, L. I., & Cidlowski, J. A. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.8.0506 · Cited by 165
Disruption of HSP90 Function Reverts Tumor Necrosis Factor-induced Necrosis to Apoptosis
Vanden Berghe, T., Kalai, M., van Loo, G., Declercq, W., & Vandenabeele, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208925200 · Cited by 165
Stressed to Death: Regulation of Apoptotic Signaling Pathways by the Heat Shock Proteins
Beere, H. M. (2001) · Science Signaling · doi:10.1126/stke.2001.93.re1 · Cited by 165
Deroo, B. J., Rentsch, C., Sampath, S., Young, J., DeFranco, D. B., & Archer, T. K. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.12.4113-4123.2002 · Cited by 164
Molecular Identification and Characterization of A and B Forms of the Glucocorticoid Receptor
Yudt, M. R. (2001) · Molecular Endocrinology · doi:10.1210/me.15.7.1093 · Cited by 164
Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids
Bianchi, M., Meng, C., & Ivashkiv, L. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160099797 · Cited by 164
IL-4 and IL-2 selectively rescue Th cell subsets from glucocorticoid-induced apoptosis
Zubiaga, A. M., Munoz, E., & Huber, B. T. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.1.107 · Cited by 163 · cited 1×
“This threshold may be subject to modulation by GCs via regulation of I B- expression during apoptosis (342, 343).”
BackgroundSavory, J. G. A., Préfontaine, G. G., Lamprecht, C., Liao, M., Walther, R. F., Lefebvre, Y. A., & Haché, R. J. G. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.3.781-793.2001 · Cited by 163
Trapp, T., & Holsboer, F. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)81590-2 · Cited by 162
Induction of NF-kappa B DNA-binding activity during the G0-to-G1 transition in mouse fibroblasts.
Baldwin, A. S., Azizkhan, J. C., Jensen, D. E., Beg, A. A., & Coodly, L. R. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.10.4943 · Cited by 162
Nucleosome remodeling at the IL-12 p40 promoter is a TLR-dependent, Rel-independent event
Weinmann, A. S., Mitchell, D. M., Sanjabi, S., Bradley, M. N., Hoffmann, A., Liou, H.-C., & Smale, S. T. (2001) · Nature Immunology · doi:10.1038/83168 · Cited by 160
CIKS, a connection to IκB kinase and stress-activated protein kinase
Leonardi, A., Chariot, A., Claudio, E., Cunningham, K., & Siebenlist, U. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190245697 · Cited by 160
Kralli, A., Bohen, S. P., & Yamamoto, K. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4701 · Cited by 160 · cited 2×
“At another level, GC sensitivity is determined by expression levels of the transporter protein LEM1 or multidrug resistance protein MDR1 (137, 138).”
BackgroundChromatin Structure and Gene Regulation in the Immune System
Smale, S. T., & Fisher, A. G. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064739 · Cited by 160 · cited 1×
“As such, chromatin remodeling effects induced by GR can vary according to the chromosomal location (381, 582).”
BackgroundReview of the Molecular and Cellular Mechanisms of Action of Glucocorticoids for Use in Asthma
Umland, S. P., Schleimer, R. P., & Johnston, S. L. (2002) · Pulmonary Pharmacology & Therapeutics · doi:10.1006/pupt.2001.0312 · Cited by 159 · cited 2×
“GC-responsive tissues with an activated inflammatory response (mediated by activated NF- B) may become resistant to GC signaling because of a blocked GR function (180, 185, 698, 699).”
BackgroundThe Role of CBP in Estrogen Receptor Cross-Talk with Nuclear Factor- B in HepG2 Cells
Harnish, D. C., Scicchitano, M. S., Adelman, S. J., Lyttle, C. R., & Karathanasis, S. K. (2000) · Endocrinology · doi:10.1210/endo.141.9.7646 · Cited by 159
Potentiation of glucocorticoid receptor transcriptional activity by sumoylation
Le Drean, Y., Mincheneau, N., Le Goff, P., & Michel, D. (2002) · Endocrinology · doi:10.1210/en.2002-220135 · Cited by 159
Ligand-dependent interaction between the estrogen receptor and the human homologues of SWI2/SNF2
Ichinose, H., Garnier, J.-M., Chambon, P., & Losson, R. (1997) · Gene · doi:10.1016/s0378-1119(96)00785-8 · Cited by 159
Östlund Farrants, A.-K., Blomquist, P., Kwon, H., & Wrange, Ö. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.2.895 · Cited by 159
Schmitz, M. L., Stelzer, G., Altmann, H., Meisterernst, M., & Baeuerle, P. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7219 · Cited by 158
Bonizzi, G., Piette, J., Merville, M.-P., & Bours, V. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00290-7 · Cited by 158
Inhibition of Glucocorticoid Receptor Binding by Nitric Oxide
Galigniana, M. D., Piwien‐Pilipuk, G., & Assreuy, J. (1999) · Molecular Pharmacology · doi:10.1124/mol.55.2.317 · Cited by 158
Li, Q., Yang, S., Maeda, Y., Sladek, F. M., Sharrocks, A. D., & Martins‐Green, M. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg028 · Cited by 158
The basic region of AP-1 specifies glucocorticoid receptor activity at a composite response element.
Miner, J. N., & Yamamoto, K. R. (1992) · Genes & Development · doi:10.1101/gad.6.12b.2491 · Cited by 158
Galasinski, S. C., Resing, K. A., Goodrich, J. A., & Ahn, N. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201174200 · Cited by 157
Delany, A. M., Gabbitas, B. Y., & Canalis, E. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240570314 · Cited by 156
Glucocorticoids: do we know how they work?
Saklatvala, J. (2002) · Arthritis Research & Therapy · doi:10.1186/ar398 · Cited by 155 · cited 2×
“To that end, many investigators are currently trying to elucidate how GCs exert their mechanism of action (177, 199).”
BackgroundDeFranco, D. B., Ming Xin, Q. I., Borror, K. C., Garabedian, M. J., & Brautigan, D. L. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-9-1215 · Cited by 154
Imasato, A., Desbois‐Mouthon, C., Han, J., Kai, H., Cato, A. C. B., Akira, S., & Li, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208140200 · Cited by 154 · cited 1×
“Recently, a genomic GC mechanism (requiring GR and de novo mRNA synthesis) was also described for the phosphatase MKP-1, which seems to be responsible for inhibition of p38 and/or ERK activities (552, 555, 556).”
BackgroundVo, N., Fjeld, C., & Goodman, R. H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.18.6181-6188.2001 · Cited by 154 · cited 1×
“Because histones (465, 469, 470), NRs (172, 173), NF- B (468), as well as cofactors (370, 371, 420, 471) can be (de)acetylated, it will be interesting to understand cross-talk of the various modifications under conditions of gene activation and GC repression (372, 442, 472–474).”
BackgroundRice, J. C., & Allis, C. D. (2001) · Nature · doi:10.1038/35104721 · Cited by 153
Trafficking of nuclear receptors in living cells
Hager, G. L., Lim, C. S., Elbi, C., & Baumann, C. T. (2000) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00100-x · Cited by 153
Keller, E. T., Chang, C., & Ershler, W. B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.42.26267 · Cited by 152
Engelbrecht, Y., de Wet, H., Horsch, K., Langeveldt, C., Hough, F. S., & Hulley, P. A. (2003) · Endocrinology · doi:10.1210/en.2002-220769 · Cited by 151 · cited 1×
“Recently, a genomic GC mechanism (requiring GR and de novo mRNA synthesis) was also described for the phosphatase MKP-1, which seems to be responsible for inhibition of p38 and/or ERK activities (552, 555, 556).”
BackgroundTsukada, J., Saito, K., Waterman, W. R., Webb, A. C., & Auron, P. E. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.11.7285 · Cited by 149
Zhao, X., Ito, A., Kane, C. D., Liao, T.-S., Bolger, T. A., Lemrow, S. M., Means, A. R., & Yao, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105086200 · Cited by 149 · cited 1×
“Nucleocytoplasmic shuttling is finally also affected by cofactor phosphorylation (407, 408).”
BackgroundDifferent glucocorticoids vary in their genomic and non‐genomic mechanism of action in A549 cells
Croxtall, J. D., Van Hal, P. T. W., Choudhury, Q., Gilroy, D. W., & Flower, R. J. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704474 · Cited by 148
Mitogen-Regulated RSK2-CBP Interaction Controls Their Kinase and Acetylase Activities
Mérienne, K., Pannetier, S., Harel‐Bellan, A., & Sassone‐Corsi, P. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.20.7089-7096.2001 · Cited by 148
Lane, S. J., Adcock, I. M., Richards, D., Hawrylowicz, C. M., Barnes, P. J., & Lee, T. H. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2680 · Cited by 147 · cited 1×
“Enhanced JNK activation in steroid-resistant patients may contribute to steroid unresponsiveness by various mechanisms, either directly by inhibiting GR activity (by blocking its phosphorylation) or indirectly by increasing AP-1 activity, which transrepresses the GC effects (717, 718).”
BackgroundIκB Is a Substrate for a Selective Pathway of Lysosomal Proteolysis
Cuervo, A. M., Hu, W., Lim, B., & Dice, J. F. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.8.1995 · Cited by 147
Chandra, J., Niemer, I., Gilbreath, J., Kliche, K. O., Andreeff, M., Freireich, E. J., Keating, M. J., & McConkey, D. J. (1998) · Blood · doi:10.1182/blood.v92.11.4220 · Cited by 147 · cited 1×
“Proteasome inhibitors were found to sensitize leukemia cells for GC therapy (309).”
BackgroundPhosphorylation of IκB-α Inhibits Its Cleavage by Caspase CPP32 in Vitro
Barkett, M., Xue, D., Horvitz, H. R., & Gilmore, T. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.47.29419 · Cited by 145 · cited 1×
“Furthermore, I B has been described as a caspase target both in vitro and in vivo (63, 70), whereas various caspases are required to mediate GC effects during apoptosis (310–312).”
BackgroundHottiger, M. O., Felzien, L. K., & Nabel, G. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3124 · Cited by 145
Regulation of nuclear factor kappaB activation by G-protein-coupled receptors.
Ye, R. D. (2001) · PubMed · Cited by 145
Abu-Amer, Y., Ross, F. P., McHugh, K. P., Livolsi, A., Peyron, J.-F., & Teitelbaum, S. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29417 · Cited by 143
Dynamic Multiphosphorylation Passwords for Activity-Dependent Gene Expression
Deisseroth, K. A., & Tsien, R. W. (2002) · Neuron · doi:10.1016/s0896-6273(02)00664-5 · Cited by 143
Dopamine-dependent responses to morphine depend on glucocorticoid receptors
Marinelli, M., Aouizerate, B., Barrot, M., Moal, M. L., & Piazza, P. V. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7742 · Cited by 142
Prolonged glucocorticoid exposure dephosphorylates histone H1 and inactivates the MMTV promoter
Lee, H., & Archer, T. (1998) · The EMBO Journal · doi:10.1093/emboj/17.5.1454 · Cited by 141
Li, J., Lin, Q., Yoon, H.-G., Huang, Z.-Q., Strahl, B. D., Allis, C. D., & Wong, J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.16.5688-5697.2002 · Cited by 141 · cited 1×
“Recent results reveal an extensive interplay between histone acetylation, methylation, and phosphorylation in transcriptional control by nuclear hormone receptors (NHR) (472) (Fig.”
BackgroundGlucocorticoids inhibit E-selectin expression by targeting NF-kappaB and not ATF/c-Jun
Brostjan, C., Anrather, J., Csizmadia, V, Natarajan, G., & Winkler, H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.8.3836 · Cited by 140
Hecht, K., Carlstedt-Duke, J., Stierna, P., Gustafsson, J.-Å., Brönnegård, M., & Wikström, A.-C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.42.26659 · Cited by 140 · cited 1×
“However, the biological significance of this dominantnegative effect by GR- has been questioned, because it is expressed at rather low levels (706, 707).”
BackgroundKallio, P. J. (1995) · Molecular Endocrinology · doi:10.1210/me.9.8.1017 · Cited by 139
Glucocorticoid receptor phosphorylation: Overview, function and cell cycle-dependence
Bodwell, J. E., Webster, J. C., Jewell, C. M., Cidlowski, J. A., Hu, J.-M., & Munck, A. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00185-4 · Cited by 138
Miura, T., Ouchida, R., Yoshikawa, N., Okamoto, K., Makino, Y., Nakamura, T., Morimoto, C., Makino, I., & Tanaka, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107098200 · Cited by 137
Du, J., Mitch, W. E., Wang, X., & Price, S. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m907258199 · Cited by 137
Nichols, M., Rientjes, J. M. J., & Stewart, A. F. (1998) · The EMBO Journal · doi:10.1093/emboj/17.3.765 · Cited by 137
Gass, P., Reichardt, H. M., Strekalova, T. V., Henn, F. A., & Tronche, F. (2001) · Physiology & Behavior · doi:10.1016/s0031-9384(01)00518-2 · Cited by 136
p65-activated Histone Acetyltransferase Activity Is Repressed by Glucocorticoids
Ito, K., Jazrawi, E., Cosío, B. G., Barnes, P. J., & Adcock, I. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103604200 · Cited by 136 · cited 2×
“In addition, GR antagonist was able to abrogate this interaction (462).”
BackgroundSzapary, D., Huang, Y. K., & Simons, S. S. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.12.0384 · Cited by 135 · cited 1×
“The key question to be addressed is whether a distinct GR cofactor configuration is involved in repression of NF- B-mediated gene expression (361, 362, 443, 461).”
BackgroundLee, D. K., Duan, H. O., & Chang, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m002285200 · Cited by 135 · cited 1×
“Because steroid receptor RNA cofactor molecules have also been described, it would be interesting to evaluate whether these molecules can modulate P-TEFb activities (508, 610).”
BackgroundGlucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras.
Brack, A., Rittner, H. L., Younge, B. R., Kaltschmidt, C., Weyand, C. M., & Goronzy, J. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119477 · Cited by 134
Feng, W., Webb, P., Nguyen, P. T., Liu, X., Li, J., Karin, M., & Kushner, P. J. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.1.0590 · Cited by 134
Li, Q., & Wränge, Ö. (1993) · Genes & Development · doi:10.1101/gad.7.12a.2471 · Cited by 133 · cited 1×
“Furthermore, GR effects in the presence of nucleosomes may strongly depend on rotational and translational positioning of the responsive elements (580, 581).”
BackgroundSchoenmakers, E., Verrijdt, G., Peeters, B., Verhoeven, G., Rombauts, W., & Claessens, F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.12290 · Cited by 132 · cited 1×
“GR DBDs bind cooperatively to specifically spaced target half-sites in the DNA (the consensus sequence is 5 -GGTACAnnnTGTTCT-3 ); the N-terminal zinc finger is involved in specific DNA interaction, whereas the C-terminal zinc finger mainly provides DNA-dependent dimerization (209, 210).”
BackgroundDeterminants of CoRNR-Dependent Repression Complex Assembly on Nuclear Hormone Receptors
Hu, X., Li, Y., & Lazar, M. A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.5.1747-1758.2001 · Cited by 132
Nuclear receptors: Structure, function and involvement in disease
Tenbaum, S. P., & Baniahmad, A. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(97)00087-3 · Cited by 131
Cippitelli, M., Sica, A., Viggiano, V., Ye, J., Ghosh, P., Birrer, M. J., & Young, H. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.21.12548 · Cited by 130
AyanlarBatuman, O., Ferrero, A., Díaz, A., & Jiménez, S. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115469 · Cited by 130
Reciprocal Recruitment of DRIP/Mediator and p160 Coactivator Complexes in Vivo by Estrogen Receptor
Burakov, D., Crofts, L. A., Chang, C.-P. B., & Freedman, L. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200099200 · Cited by 128
de Lange, P., Koper, J. W., Huizenga, N. A. T. M., Brinkmann, A. O., de Jong, F. H., Karl, M., Chrousos, G. P., & Lamberts, S. W. J. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.8.9949 · Cited by 128
Zuo, Z., Urban, G., Scammell, J. G., Dean, N. M., McLean, T. K., Aragon, I., & Honkanen, R. E. (1999) · Biochemistry · doi:10.1021/bi990842e · Cited by 126
Davani, B., Khan, A., Hult, M., Mårtensson, E., Okret, S., Efendić, S., Jörnvall, H., & Oppermann, U. C. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000600200 · Cited by 126
Doucas, V., Shi, Y., Miyamoto, S., West, A., Verma, I., & Evans, R. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220413297 · Cited by 125 · cited 8×
“These data suggest that the presence of a conserved RHD alone is not sufficient to mediate repression and that an additional input is given by the unique transactivation functions of p65 (227).”
BackgroundInfluentialWest, M. J., Lowe, A. D., & Karn, J. (2001) · Journal of Virology · doi:10.1128/jvi.75.18.8524-8537.2001 · Cited by 125 · cited 2×
“Furthermore, NF-B was found to stimulate transcriptional elongation of RNA polymerase II by binding transcription elongation factor (P-TEFb), which phosphorylates RNA polymerase II CTD at Ser2 and Ser5 (606, 607).”
BackgroundEberhardt, W., Schulze, M., Engels, C., Klasmeier, E., & Pfeilschifter, J. (2002) · Molecular Endocrinology · doi:10.1210/me.2001-0278 · Cited by 124
Liao, J., Barthel, A., Nakatani, K., & Roth, R. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.42.27320 · Cited by 123
Schmidt, P., Holsboer, F., & Spengler, D. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.4.0613 · Cited by 123
González, M. V., Jiménez, B., Berciano, M. T., González‐Sancho, J. M., Caelles, C., Lafarga, M., & Múñoz, A. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.5.1199 · Cited by 123 · cited 1×
“with activation of JNK and ERK1/2 (via increased MKP1 levels), which prevented AP-1 phosphorylation (283, 286, 552, 553) (Fig.”
BackgroundRecruitment of p300 by C/EBPβ triggers phosphorylation of p300 and modulates coactivator activity
Schwartz, C., Schachtrup, K., Mink, S., Schmolke, M., Budde, B., Wenning, D., & Klempnauer, K.-H. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg076 · Cited by 122
Transcriptional inhibition by a glucocorticoid receptor-β-galactosidase fusion protein
Oro, A. E., Hollenberg, S. M., & Evans, R. M. (1988) · Cell · doi:10.1016/0092-8674(88)90255-3 · Cited by 122 · cited 7×
“Deleting the ligand-binding domain (LBD) diminished transrepression, whereas replacing it with an unrelated -galactosidase moiety greatly restored the transrepressive action, arguing for an exclusively steric role of the LBD (231).”
BackgroundInfluentialCa2+‐dependent block of CREB–CBP transcription by repressor DREAM
Ledo, F., Kremer, L., Mellström, B., & Naranjo, J. R. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf440 · Cited by 122
Li, Q., & Wrange, Ö. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4375 · Cited by 122 · cited 1×
“Furthermore, GR effects in the presence of nucleosomes may strongly depend on rotational and translational positioning of the responsive elements (580, 581).”
BackgroundNegative cross‐talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells
Sengupta, S., Vonesch, J., Waltzinger, C., Zheng, H., & Wasylyk, B. (2000) · The EMBO Journal · doi:10.1093/emboj/19.22.6051 · Cited by 121
Pugeat, M., Emptoz-Bonneton, A., Perrot, D., Rocle, B., Lejeune, H., Grenot, C., Déchaud, H., Brébant, C., Motin, J. P., & Cuilleron, C. Y. (1989) · Clinical Chemistry · doi:10.1093/clinchem/35.8.1675 · Cited by 121 · cited 1×
“CBG homeostasis is normally restored after 1 or 2 d (132, 133).”
BackgroundRegulation of TNF Expression by Multiple Mitogen-Activated Protein Kinase Pathways
Zhu, W., Downey, J. S., Gu, J., Di Padova, F., Gram, H., & Han, J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6349 · Cited by 120
Cytokine Modulators as Novel Therapies for Asthma
Barnes, P. J. (2002) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.111901.111143 · Cited by 120 · cited 1×
“Combinations of GCs with MAPK inhibitors or -adrenergic agonists have already proven their therapeutic efficacy in the treatment of inflammatory pathologies (161, 163, 181, 182, 525, 698, 722).”
BackgroundCarter, A. B., & Hunninghake, G. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003599200 · Cited by 119 · cited 1×
“Besides GR, also the TBP was found to be a direct substrate for p38 MAPK phosphorylation (712, 713) and may further codetermine steroid sensitivity during GR transrepression (599, 714–716).”
BackgroundCytokines: promoters and dampeners of autoimmunity
Hill, N. J., & Sarvetnick, N. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00403-x · Cited by 118
Critical role of nuclear factor‐κB and stress‐activated protein kinases in steroid unresponsiveness
Bantel, H., Schmitz, M. L., Raible, A., Gregor, M., & Schulze‐Osthoff, K. (2002) · The FASEB Journal · doi:10.1096/fj.02-0223fje · Cited by 118
Glucocorticoids Attenuate T Cell Receptor Signaling
Van Laethem, F., Baus, E., Smyth, L. A., Andris, F., Bex, F., Urbain, J., Kioussis, D., & Leo, O. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.7.803 · Cited by 118
The heat shock paradox: does NF‐ κ B determine cell fate?
DeMeester, S. L., Buchman, T. G., & Cobb, J. P. (2001) · The FASEB Journal · doi:10.1096/fj.00-0170hyp · Cited by 118 · cited 1×
“induction of the NF- B inhibitor I B (293).”
Bagatell, R., Khan, O., Paine-Murrieta, G. D., Taylor, C. W., Akinaga, S., & Whitesell, L. J. (2001) · PubMed · Cited by 118
Tao, Y., Williams-Skipp, C., & Scheinman, R. I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000526200 · Cited by 117 · cited 3×
“repress NF- B without affecting AP-1 transrepression (246),”
BackgroundResultInfluentialNovel IκBα Proteolytic Pathway in WEHI231 Immature B Cells
Miyamoto, S., Seufzer, B. J., & Shumway, S. D. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.19 · Cited by 117
Dissociative Glucocorticoid Activity of Medroxyprogesterone Acetate in Normal Human Lymphocytes
Bamberger, C. M., Else, T., Bamberger, A., Beil, F. U., & Schulte, H. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6091 · Cited by 116
Bourgeois, S., Gruol, D. J., Newby, R. F., & Rajah, F. M. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.7.8105374 · Cited by 116 · cited 2×
“At another level, GC sensitivity is determined by expression levels of the transporter protein LEM1 or multidrug resistance protein MDR1 (137, 138).”
BackgroundWilckens, T. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89021-5 · Cited by 116 · cited 1×
“For example, synthetic GCs differ from endogenous GCs in binding to CBG, tissuespecific metabolism, affinity for various GRs, and interaction with transcription factors (174).”
BackgroundDNA Binding-Independent Induction of I B Gene Transcription by PPAR
Delerive, P., Bosscher, K. D., Berghe, W. V., Fruchart, J., Haegeman, G., & Staels, B. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.5.0826 · Cited by 116 · cited 1×
“Interestingly, PPAR- ligand-dependent recruitment of vitamin D receptor-interacting protein (DRIP)/thyroid receptor-activated protein (TRAP) complex together with Sp1-flanking NF- B lies at the basis of the observed transcriptional synergy (265, 267).”
BackgroundSelf-citationWissink, S., van Heerde, E. C., Schmitz, M. L., Kalkhoven, E., van der Burg, B., Baeuerle, P. A., & van der Saag, P. T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22278 · Cited by 115 · cited 2×
“the GR activity have also been mapped (245).”
Backgroundvan de Stolpe, A., Caldenhoven, E., Raaijmakers, J. A. M., van der Saag, P. T., & Koenderman, L. (1993) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/8.3.340 · Cited by 114
Rogatsky, I., Hittelman, A. B., Pearce, D., & Garabedian, M. J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.5036 · Cited by 114
Transcriptional activation: risky businessPreprint
Tansey, W. P. (2001) · Genes & Development · doi:10.1101/gad.896501 · Cited by 114
Estrogen receptor-mediated cross-talk with growth factor signaling pathways
Kato, S. (2001) · Breast Cancer · doi:10.1007/bf02967472 · Cited by 112
Navigating Steroid Hormone Receptors through the Nuclear Compartment
DeFranco, D. B. (2002) · Molecular Endocrinology · doi:10.1210/me.16.7.1449 · Cited by 111
Localization of glucocorticoid hormone receptors in mitochondria of human cells
Scheller, K., Sekeris, C. E., Krohne, G., Hock, R., Hansen, I. A., & Scheer, U. (2000) · European Journal of Cell Biology · doi:10.1078/s0171-9335(04)70033-3 · Cited by 110 · cited 1×
“Finally, differences in cell-culturing conditions and cell proliferation rate have been found to induce variations in GC-induced I B gene expression, depending on gene clusters involved in energy metabolism (313, 314).”
BackgroundReichman, T., Muñiz, L. C., & Mathews, M. B. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.1.343-356.2002 · Cited by 110
Kym, P. R., Kort, M. E., Coghlan, M. J., Moore, J. L., Tang, R., Ratajczyk, J. D., Larson, D. P., Elmore, S. W., Pratt, J. K., Stashko, M. A., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020335m · Cited by 109
Nelson, G., Paraoan, L., Spiller, D. G., Wilde, G. J. C., Browne, M. A., Djali, P. K., Unitt, J. F., Sullivan, E., Floettmann, E., & White, M. R. H. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.6.1137 · Cited by 109
From ligand to response: generating diversity in nuclear receptor coregulator function
McKenna, N. J., & O’Malley, B. W. (2000) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00112-6 · Cited by 109 · cited 1×
“The key question to be addressed is whether a distinct GR cofactor configuration is involved in repression of NF- B-mediated gene expression (361, 362, 443, 461).”
BackgroundModulation of AP‐1 activity by nitric oxide (NO) in vitro: NO‐mediated modulation of AP‐1
Tabuchi, A., Sano, K., Oh, E., Tsuchiya, T., & Tsuda, M. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00839-6 · Cited by 109
Crosstalk pathway for inhibition of glucocorticoid-induced apoptosis by T cell receptor signaling
Jamieson, C., & Yamamoto, K. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7319 · Cited by 108
Nitrosative Stress-induced Apoptosis through Inhibition of NF-κB
Marshall, H. E., & Stamler, J. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201638200 · Cited by 108
Ohtsuka, T., Kubota, A., Hirano, T., Watanabe, K., Yoshida, H., Tsurufuji, M., Iizuka, Y., Konishi, K., & Tsurufuji, S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.3.1651 · Cited by 108
Berghe, W. V., Francesconi, E., Bosscher, K. D., Resche-Rigon, M., & Haegeman, G. (1999) · PubMed · Cited by 108
Self-citationGlucocorticoid Repression of AP-1 Is Not Mediated by Competition for Nuclear Coactivators
Bosscher, K. D., Berghe, W. V., & Haegeman, G. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.2.0591 · Cited by 108
Self-citationNishi, M., Ogawa, H., Ito, T., Matsuda, K., & Kawata, M. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.7.0659 · Cited by 108 · cited 1×
“] with respect to its cofactor partners (274, 392, 457, 458).”
BackgroundKaltschmidt, B., Kaltschmidt, C., Hehner, S. P., Dröge, W., & Schmitz, M. L. (1999) · Oncogene · doi:10.1038/sj.onc.1202657 · Cited by 108
Molecular interactions between glucocorticoids and long-acting β2-agonists
Adcock, I. M., Maneechotesuwan, K., & Usmani, O. S. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.129705 · Cited by 107 · cited 1×
“Combinations of GCs with MAPK inhibitors or -adrenergic agonists have already proven their therapeutic efficacy in the treatment of inflammatory pathologies (161, 163, 181, 182, 525, 698, 722).”
BackgroundNishio, Y., Isshiki, H., Kishimoto, T., & Akira, S. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.3.1854 · Cited by 107
Bhattacharjee, R. N., Banks, G. C., Trotter, K. W., Lee, H.-L., & Archer, T. K. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.16.5417-5425.2001 · Cited by 106 · cited 1×
“Several reports have already focused on the association of GR with components of the BRG-1 and/or SWI/SNF complex and showed that GR can alter chromatin-remodeling properties (564–570); recruitment was demonstrated to depend on surrounding histone H1 phosphorylation (506, 571, 572) and to require the transactivation d…”
BackgroundRider, L. G., Hirasawa, N., Santini, F., & Beaven, M. A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.6.2374 · Cited by 105
Cellular identity and lineage choice
Fisher, A. G. (2002) · Nature reviews. Immunology · doi:10.1038/nri958 · Cited by 105
Harant, H., Andrew, P. J., Reddy, G. S., Foglar, E., & Lindley, I. J. D. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00063.x · Cited by 105
Barnes, P. J., & Adcock, I. M. (1995) · QJM · doi:10.1093/oxfordjournals.qjmed.a069089 · Cited by 105 · cited 1×
“There is a huge drawback, however, to the beneficial use of GCs, because treatments with high doses for longer periods cannot only cause resistance to the steroidbased therapy (184, 185), but can also be accompanied by a range of detrimental side-effects (178, 186–188).”
BackgroundFactor-specific modulation of CREB-binding protein acetyltransferase activity
Perissi, V., Dasen, J. S., Kurokawa, R., Wang, Z., Korzus, E., Rose, D. W., Glass, C. K., & Rosenfeld, M. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3652 · Cited by 104
Michael, L. F., Asahara, H., Shulman, A. I., Kraus, W. L., & Montminy, M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1596-1603.2000 · Cited by 104
Aziz, K. E., & Wakefield, D. (1996) · Cellular Immunology · doi:10.1006/cimm.1996.0010 · Cited by 104
Amrani, Y., Lazaar, A. L., & Panettieri, R. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.2128 · Cited by 103 · cited 23×
“Only recently, Adcock et al. (229) succeeded in showing an interaction between endogenous p65 and GR, using IL-1- and dexamethasone (DEX)-costimulated A549 cells, which contain a considerable amount of immunoreactive GR.”
BackgroundInfluentialNuclear receptor cofactors as chromatin remodelers
Lemon, B. D., & Freedman, L. P. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)00010-6 · Cited by 103
Espinosa, L., Inglés-Esteve, J., Robert-Moreno, A., & Bigas, A. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-07-0404 · Cited by 103
Termination of Acute-Phase Response
Koj, A. (1998) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(97)00435-7 · Cited by 102
Cytokines: regulation of the hypothalamo-pituitary-adrenocortical axis
JOHN, C., & BUCKINGHAM, J. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00009-7 · Cited by 102
Sousa, A. R., Lane, S. J., Soh, C., & Lee, T. H. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70325-8 · Cited by 102 · cited 1×
“Enhanced JNK activation in steroid-resistant patients may contribute to steroid unresponsiveness by various mechanisms, either directly by inhibiting GR activity (by blocking its phosphorylation) or indirectly by increasing AP-1 activity, which transrepresses the GC effects (717, 718).”
BackgroundA Subclass of Ras Proteins That Regulate the Degradation of IκB
Fenwick, C., Na, S.-Y., Voll, R. E., Zhong, H., Im, S.-Y., Lee, J. W., & Ghosh, S. (2000) · Science · doi:10.1126/science.287.5454.869 · Cited by 102
Zhang, X. K., Dong, J., & Chiu, J. F. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)92969-8 · Cited by 101
Baumann, H., Jahreis, G. P., & Morella, K. K. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45700-6 · Cited by 101
Newton, R. C., Hart, L. A., Stevens, D. A., Bergmann, M., Donnelly, L., Adcock, I. M., & Barnes, P. J. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2540081.x · Cited by 101
The Nuclear Corepressors Recognize Distinct Nuclear Receptor Complexes
Cohen, R. N. (2000) · Molecular Endocrinology · doi:10.1210/me.14.6.900 · Cited by 101
Parker, M. G. (1993) · doi:10.1093/oso/9780199633937.001.0001 · Cited by 100
Novel Mechanism of Steroid Action in Skin through Glucocorticoid Receptor Monomers
Radoja, N., Komine, M., Jho, S. H., Blumenberg, M., & Tomic-Canic, M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.12.4328-4339.2000 · Cited by 100 · cited 1×
“Detailed footprinting revealed that the function of nGREs is to instruct GR to bind as a monomer (213).”
BackgroundWebster, J. C., Huber, R., Hanson, R. L., Collier, P. M., Haws, T. F., Mills, J. K., Burn, T. C., & Allegretto, E. A. (2002) · Endocrinology · doi:10.1210/en.2002-220188 · Cited by 100 · cited 1×
“A c-IAP2 promoter variant in which the GRE site had been mutated resulted not only in loss of GC-mediated induction, but also, surprisingly enough, in loss of GC repression of the NF- B activity (238).”
BackgroundLiu, J. (1999) · Molecular Endocrinology · doi:10.1210/me.13.3.355 · Cited by 99 · cited 1×
“Other levels of regulation that determine GC sensitivity include variations in the receptor protein (mutations, polymorphisms, isoforms) (141– 147), alternative receptor dimerization (GR heterodimerization has been described with MR, PR, and AR) (144, 148–151), presence of GC modulatory element binding proteins (152–…”
BackgroundCharacterization of mechanisms of interleukin-6 gene repression by estrogen receptor
Kurebayashi, S., Miyashita, Y., Hirose, T., Kasayama, S., Akira, S., & Kishimoto, T. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(96)00175-6 · Cited by 99
Boruk, M., Savory, J. G. A., & Haché, R. J. G. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.11.0191 · Cited by 98 · cited 1×
“This type of regulation is not without precedent, because a cooperative effect between the GR and NF-IL6 has previously been demonstrated for activation of the 1-acid glycoprotein gene (263, 264).”
BackgroundComparison of the mechanisms of nongenomic actions of thyroid hormone and steroid hormones
Davis, P. J., Tillmann, H. C., Davis, F. B., & Wehling, M. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03344022 · Cited by 98
Chen, F. E., Huang, D.-B., Noro, B., Thanos, D., & Ghosh, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200007200 · Cited by 97
Therapeutic potential of selective modulators of nuclear receptor action
Resche-Rigon, M., & Gronemeyer, H. (1998) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(98)80126-9 · Cited by 97
Interpretation of the complexity of innate immune responses by functional genomics
Ricciardi‐Castagnoli, P., & Granucci, F. (2002) · Nature reviews. Immunology · doi:10.1038/nri936 · Cited by 96 · cited 10×
“00/0 Endocrine Reviews 24(4):488–522 Printed in U.”
BackgroundInfluentialTonko, M., Ausserlechner, M. J., Bernhard, D., Helmberg, A., & Kofler, R. (2001) · The FASEB Journal · doi:10.1096/fj.00-0327com · Cited by 95
Carty, S. M., & Greenleaf, A. L. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m200029-mcp200 · Cited by 95
Arginine Methylation of STAT1 Regulates Its Dephosphorylation by T Cell Protein Tyrosine Phosphatase
Zhu, W., Mustelin, T., & David, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200346200 · Cited by 94 · cited 1×
“Furthermore, PRMT-1 has been reported to affect transcription by methylation of the transcription factor STAT1 (495), which further regulates its dephosphorylation by phosphatases (496).”
BackgroundGlucocorticoid Effects on NF-κB Binding in the Transcription of the ICAM-1 Gene
Lidén, J., Rafter, I., Truss, M., Gustafsson, J.-Α., & Okret, S. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3079 · Cited by 94
Chaudhary, L. R., & Avioli, L. V. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.28.16591 · Cited by 93
Straub, R. H., GÜNZLER, C., Miller, L. E., Cutolo, M., Schölmerich, J., & Schill, S. (2002) · The FASEB Journal · doi:10.1096/fj.02-0085com · Cited by 92 · cited 1×
“Combinations of GCs with MAPK inhibitors or -adrenergic agonists have already proven their therapeutic efficacy in the treatment of inflammatory pathologies (161, 163, 181, 182, 525, 698, 722).”
BackgroundPlasma membrane-resident glucocorticoid receptors in rodent lymphoma and human leukemia models
Gametchua, B. (1999) · Steroids · doi:10.1016/s0039-128x(98)00097-x · Cited by 91
Glucocorticoid-mediated transrepression is regulated by histone acetylation and DNA methylation
Kagoshima, M., Wilcke, T., Ito, K., Tsaprouni, L., Barnes, P. J., Punchard, N. A., & Adcock, I. M. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01332-2 · Cited by 89 · cited 1×
“Finally, a role for DNA methylation in both GR transrepression and transactivation has been described (497, 498).”
BackgroundStructure and Dynamic Properties of a Glucocorticoid Receptor-Induced Chromatin Transition
Fletcher, T. M., Ryu, B., Baumann, C. T., Warren, B. S., Fragoso, G., John, S., & Hager, G. L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.17.6466-6475.2000 · Cited by 89
RAY, P. K., Farrow, S. N., Daly, M. C., Talabot, F., & SEARLE, N. (1997) · Biochemical Journal · doi:10.1042/bj3280707 · Cited by 88
Rabbitt, E. H., Lavery, G. G., Walker, E. A., Cooper, M. S., Stewart, P. M., & Hewison, M. (2002) · The FASEB Journal · doi:10.1096/fj.01-0582com · Cited by 88
Thiele, K., Bierhaus, A., Autschbach, F., Hofmann, M. A., Stremmel, W., Thiele, H. G., Ziegler, R., & Nawroth, P. P. (1999) · Gut · doi:10.1136/gut.45.5.693 · Cited by 88 · cited 1×
“In vascular endothelial tissue from patients suffering from Crohn’s disease, elevated levels of I B- were found after GC treatment, whereas in mononuclear cell infiltrates no such GC-induced up-regulation could be demonstrated (315).”
BackgroundSovak, M. A., Arsura, M., Zanieski, G., Kavanagh, K. T., & Sonenshein, G. E. (1999) · PubMed · Cited by 87
Scott, D. K., Strömstedt, P.-E., Wang, J.-C., & Granner, D. K. (1998) · Molecular Endocrinology · doi:10.1210/me.12.4.482 · Cited by 86
Role of DNA Methylation and Histone Acetylation in Steroid Receptor Expression in Breast Cancer
Lan, Y., Yang, X., & Davidson, N. E. (2001) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1011308707512 · Cited by 85
Utley, R. T., Côté, J., Owen-Hughes, T., & Workman, J. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.19.12642 · Cited by 85 · cited 1×
“Also, nucleosome binding by the RHD of p65 can specifically be stimulated by SWI/SNF but not by BRG1/BRG-1-associated factor (BAF)-155 complexes (583, 584).”
BackgroundLin, D.-Y., Lai, M., Ann, D. K., & Shih, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300387200 · Cited by 85
Inhibition versus induction of apoptosis by proteasome inhibitors depends on concentration
Lin, K., Baraban, J. M., & Ratan, R. R. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400384 · Cited by 85
Lin, K.-I., DiDonato, J. A., Hoffmann, A., Marie Hardwick, J., & Ratan, R. R. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.7.1479 · Cited by 84
TAFII105 mediates activation of anti‐apoptotic genes by NF‐κB
Yamit-Hezi, A., & Dikstein, R. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5161 · Cited by 84
Loven, M. A., Muster, N., Yates, J. R., & Nardulli, A. M. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0280 · Cited by 83 · cited 1×
“lating acetylation of histones and ER (453).”
Activators and repressors: making use of chromatin to regulate transcription
Wolffe, A. P., Wong, J., & Pruss, D. (1997) · Genes to Cells · doi:10.1046/j.1365-2443.1997.1260323.x · Cited by 83 · cited 1×
“Coactivator molecules are characterized by an intrinsic histone acetyltransferase (HAT) activity, believed to result in a more relaxed chromatin environment, which promotes gene activation (344).”
BackgroundUbc9 Is a Novel Modulator of the Induction Properties of Glucocorticoid Receptors
Kaul, S. C., Blackford, J. A., Cho, S., & Simons, S. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112330200 · Cited by 82
Xu, X., Otsuki, M., Saito, H., Sumitani, S., Yamamoto, H., Asanuma, N., Kouhara, H., & Kasayama, S. (2001) · Endocrinology · doi:10.1210/endo.142.8.8340 · Cited by 82
c-Jun NH2-terminal Kinase-mediated Redox-dependent Degradation of IκB
Das, K. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006206200 · Cited by 82 · cited 1×
“degradation of I B in a redox-dependent manner (282); be-”
BackgroundWang, H., Zentner, M. D., Deng, H.-T., Kim, K.-J., Wu, R., Yang, P., & Ann, D. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8600 · Cited by 82
Continuous recycling: a mechanism for modulatory signal transduction.
Freeman, B. C., & Yamamoto, K. R. (2001) · TIBS -Trends in Biochemical Sciences. Regular ed · doi:10.1016/s0968-0004(01)01834-5 · Cited by 81 · cited 1×
“Other levels of regulation that determine GC sensitivity include variations in the receptor protein (mutations, polymorphisms, isoforms) (141– 147), alternative receptor dimerization (GR heterodimerization has been described with MR, PR, and AR) (144, 148–151), presence of GC modulatory element binding proteins (152–…”
BackgroundO’Connor, M. J., Zimmermann, H., Nielsen, S., Bernard, H.-U., & Kouzarides, T. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3574-3581.1999 · Cited by 80
Molecular Mechanisms of Immunosuppression and Anti-inflammatory Activities by Glucocorticoids
Didonato, J. A., Saatcioglu, F., & Karin, M. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm/154.2_pt_2.s11 · Cited by 79
A Weak TATA Box Is a Prerequisite for Glucocorticoid-dependent Repression of the Osteocalcin Gene
Meyer, T., Carlstedt-Duke, J., & Starr, D. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30709 · Cited by 79 · cited 1×
“In addition, for some of these genes the mechanism was also found to involve GR-dependent displacement of another factor (for example TATA-binding protein TBP) or DNA-independent tethering by GR of another transcription factor (214, 215) (Fig.”
BackgroundDeterminants of subcellular distribution of the glucocorticoid receptor
Sackey, F. N. (1996) · Molecular Endocrinology · doi:10.1210/me.10.10.1191 · Cited by 77 · cited 1×
“DEX is about 5 min) to result in biological effects (655, 656).”
BackgroundMeyer, T., Gustafsson, J.-Α., & Carlstedt‐Duke, J. (1997) · DNA and Cell Biology · doi:10.1089/dna.1997.16.919 · Cited by 76
A coactivator code for transcription
Gamble, M. J., & Freedman, L. P. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02076-5 · Cited by 75 · cited 2×
“By analogy with histone code (465, 469, 470, 517), the interplay of modifications at the cofactor (370, 371) and transcription factor levels (418, 518–521) may similarly have important functional implications (such as, e.”
BackgroundGene Repression by Coactivator Repulsion
Senger, K. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00090-3 · Cited by 75 · cited 1×
“As an alternative to cofactor competition, a coactivator repulsion model, based on transcription factor domains that prevent enhanceosome-dependent recruitment of the CBP-PolII holoenzyme complex by repulsion, was suggested (415, 426).”
ATP-Dependent Release of Glucocorticoid Receptors from the Nuclear Matrix
Tang, Y., & DeFranco, D. B. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.1989 · Cited by 75
Research works printed but not linked: 10
- Delerive, 2002, DNA-binding independent regulation of IκB-α gene transcription by PPARα., Mol Endocrinol, 16, 1029
- Benecke, 1998, Nuclear receptor coactivators as potential therapeutical targets: the HATs on the mouse trap., Gene Ther Mol Biol, 3, 1
- Herrlich, 2001, Cross-talk between glucocorticoid receptor and AP-1., Oncogene, 20, 2465, 10.1038/sj.onc.1204388 · DOI · Paper page
- Lidén, 2000, Glucocorticoid effects on NF-κB binding in the transcription of the ICAM-1 gene., Biochem Biophys Res Commun, 273, 1008, 10.1006/bbrc.2000.3079 · DOI
- Chen, 1999, Multiple glucocorticoid receptor transcripts in membrane glucocorticoid receptor-enriched S-49 mouse lymphoma cells., J Cell Biochem, 74, 418, 10.1002/(sici)1097-4644(19990901)74:3<418::aid-jcb10>3.0.co;2-6 · DOI
- Webster, 2001, Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative β isoform: a mechanism for the generation of glucocorticoid resistance., Proc Natl Acad Sci USA, 98, 6865, 10.1073/pnas.121455098 · DOI · Paper page
- De Vera, 1997, Dexamethasone suppresses iNOS gene expression by upregulating IκBα and inhibiting NF-κB, Am J Physiol, 273, G1290
- Han, 1999, Glucocorticoids prevent NF-κB activation by inhibiting the early release of platelet-activating factor in response to lipopolysaccharide., Eur J Immunol, 29, 1334, 10.1002/(sici)1521-4141(199904)29:04<1334::aid-immu1334>3.0.co;2-0 · doi:10.1002/(sici)1521-4141(199904)29:04<1334::aid-immu1334>3.0.co;2-0
- Sengupta, 2000, Negative cross-talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells., EMBO J, 19, 6051, 10.1093/emboj/19.22.6051 · DOI
- Lee, 1998, Prolonged glucocorticoid exposure dephosphorylates histone H1 and inactivates the MMTV promoter., EMBO J, 17, 1454, 10.1093/emboj/17.5.1454 · DOI
Cited by
Stress and the brain: from adaptation to disease
de Kloet, E. R., Joëls, M., & Holsboer, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1683 · Cited by 4,621
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149
NF-κB in biology and targeted therapy: new insights and translational implications
Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., & Zhang, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01757-9 · Cited by 2,047
Integrating cell-signalling pathways with NF-κB and IKK function
Perkins, N. D. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2083 · Cited by 2,350
“Nuclear receptors (NRs) are transcription factors that are typically regulated by the binding of specific ligands, such as glucocorticoids, oestrogen, thyroid hormone and retinoic aci”
BackgroundGene-specific control of inflammation by TLR-induced chromatin modifications
Foster, S. L., Hargreaves, D. C., & Medzhitov, R. (2007) · Nature · doi:10.1038/nature05836 · Cited by 1,344
Metadata
- Authors
- De Bosscher, K., Vanden Berghe, W., & Haegeman, G.
- Affiliations
- Department of Molecular Biology, Ghent University, K. L. Ledeganckstraat 35, 9000 Gent, Belgium
- Ghent University (BE)
- Corresponding author
- Haegeman, Guy
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2003-08-01
- Volume
- 24
- Issue
- 4
- Pages
- 488-522
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2053125671
- Cited by
- 898
- References
- 808
- Citations by year
- 2026: 22 · 2025: 25 · 2024: 13 · 2023: 24 · 2022: 22 · 2021: 41 · 2020: 30 · 2019: 20 · 2018: 26 · 2017: 46 · 2016: 42 · 2015: 52 · 2014: 47 · 2013: 41 · 2012: 48
- FWCI
- 3.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- glucocorticoid receptor, NF-κB, activator protein-1, gene repression, anti-inflammatory mechanism, inflammation, signal transduction, glucocorticoids, transcriptional regulation, rheumatoid arthritis, asthma, allograft rejection, allergic skin diseases
- MeSH terms
- Gene Expression Regulation, Glucocorticoids, Humans, Inflammation, Receptors, Glucocorticoid, Signal Transduction, NF-kappa B, Transcription Factor AP-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.